13F reference period
Q3 2026
CUSIP: 98937L105
13F reference period
Q3 2026
Institutions Reporting
108
Shares (Excl. Options)
Price
$26.97
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 108 institutions filings for Q3 2026.
Security key
98937L105
13F reference period
Q3 2026
13F holders
108
13D/G owners
10
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 98937L105:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 12% | +23% | $228,098,473 | +$43,064,817 | 8,094,339 | +23% | Wellington Management Group LLP | 30 Sep 2026 |
| FMR LLC | 14% | +30% | $277,876,336 | +$109,228,632 | 7,652,255 | +65% | FMR LLC | 31 Dec 2025 |
| InnoCare Pharma Inc. | 10% | +11% | $217,630,000 | +$62,180,000 | 7,000,000 | +40% | InnoCare Pharma Inc. | 26 Aug 2026 |
| SR ONE CAPITAL MANAGEMENT, LLC | 7.7% | -19% | $148,264,043 | 5,037,854 | 0% | SR One Capital Management, LLC | 13 Aug 2026 | |
| BlackRock, Inc. | 5% | $88,651,285 | 3,287,021 | BlackRock, Inc. | 30 Sep 2026 | |||
| Enavate Sciences GP, LLC | 4.9% | -34% | $100,899,610 | -$20,947,043 | 3,245,404 | -17% | Enavate Sciences GP, LLC | 19 Aug 2026 |
| MOULDER LEON O JR | 5.1% | +6% | $67,767,315 | +$4,017,777 | 3,220,880 | +6.3% | MOULDER LEON O JR | 29 Apr 2026 |
| Longitude Capital Partners IV, LLC | 4.9% | $58,425,578 | 2,631,522 | Patrick G. Enright | 09 Oct 2025 | |||
| Novo Holdings A/S | 4.7% | -12% | $44,400,000 | -$4,772,267 | 2,000,000 | -9.7% | Novo Holdings A/S | 30 Sep 2025 |
| Xencor Inc | 1.5% | $28,180,000 | 1,000,000 | Xencor, Inc. | 30 Sep 2026 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 12% | 8,094,339 | 0.04% | $218,304,324 | |
| SR ONE CAPITAL MANAGEMENT, LP | 7.7% | 5,037,854 | 12% | $135,870,922 | |
| NEA Management Company, LLC | 6.2% | 4,023,219 | 8% | $108,506,217 | |
| FEDERATED HERMES, INC. | 4.8% | 3,107,308 | 0.12% | $83,804,097 | |
| Capital International Investors | 4.5% | 2,925,343 | 0.02% | $78,896,501 | |
| ENAVATE SCIENCES GP, LLC | 4.5% | 2,919,159 | 28% | $78,729,718 | |
| Polar Capital Holdings Plc | 3.7% | 2,405,374 | 0.18% | $64,872,937 | |
| Royalty Pharma Sub-Manager, LLC | 3.7% | 2,388,150 | 33% | $64,408,406 | |
| Fairmount Funds Management LLC | 3.6% | 2,371,358 | 4% | $63,955,525 | |
| STATE STREET CORP | 2.9% | 1,882,634 | 0% | $50,774,639 | |
| NVP ASSOCIATES, LLC | 2.8% | 1,838,482 | 18% | $49,583,860 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.6% | 1,722,706 | 0% | $46,461,381 | |
| ALLIANCEBERNSTEIN L.P. | 1.6% | 1,060,539 | 0.01% | $28,602,737 | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 1,060,277 | 0% | $28,604,081 | |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 833,288 | 0.02% | $22,473,777 | |
| EcoR1 Capital, LLC | 1.2% | 789,500 | 1% | $21,292,815 | |
| GOLDMAN SACHS GROUP INC | 1.2% | 774,621 | 0% | $20,891,529 | |
| BANK OF AMERICA CORP /DE/ | 1% | 683,308 | 0% | $18,428,817 | |
| Woodline Partners LP | 0.91% | 590,969 | 0.05% | $15,938,434 | |
| ArrowMark Colorado Holdings LLC | 0.81% | 527,976 | 0.68% | $14,239,513 | |
| Rock Springs Capital Management LP | 0.77% | 502,077 | 0.73% | $13,541,017 | |
| NEXTBio Capital Management LP | 0.65% | 426,736 | 4.9% | $11,509,070 | |
| Vestal Point Capital, LP | 0.61% | 395,000 | 0.28% | $10,653,150 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.59% | 384,150 | 0% | $10,360,526 | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.51% | 334,057 | 1.1% | $9,009,517 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 51,626,349 | $1,392,434,151 | +$155,517,307 | $26.97 | 108 |
| 2026 Q2 | 61,266,969 | $1,548,569,766 | +$88,389,128 | $25.38 | 143 |
| 2026 Q1 | 56,887,525 | $1,112,055,053 | +$218,738,134 | $19.55 | 138 |
| 2025 Q4 | 41,561,367 | $1,504,857,337 | +$255,199,550 | $36.31 | 118 |
| 2025 Q3 | 34,774,383 | $771,813,059 | +$23,276,708 | $22.20 | 78 |
| 2025 Q2 | 34,055,191 | $329,977,952 | +$15,611,752 | $9.69 | 72 |
| 2025 Q1 | 32,489,801 | $256,715,238 | +$5,759,402 | $7.90 | 67 |
| 2024 Q4 | 31,699,756 | $259,632,936 | +$20,083,837 | $8.19 | 65 |
| 2024 Q3 | 24,771,152 | $418,526,187 | +$418,475,122 | $16.92 | 44 |